Posts by: Janet Stewart, MSc

Janet Stewart, MSc

Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.

July 9, 2018July 12, 2018

Protein Involved in PAH Development a Potential Therapeutic Target, Study Suggests

News, PAH News

A certain protein found on white blood cells, which plays a role in causing pulmonary arterial hypertension (PAH), may be a potential new therapeutic target, a study in mice ... Read more

May 1, 2018

Actelion Seeks Expanded Approval for Opsumit as Treatment for Inoperable CTEPH

News

Actelion Pharmaceuticals submitted a supplemental new drug application to U.S. regulatory authorities seeking expanded approval for Opsumit (macitentan) to treat inoperable chronic thromboembolic pulmonary hypertension (CTEPH). The U.S. Food and ... Read more

April 9, 2018April 9, 2018

Traditional Chinese Medicine Shows Promise for Treating PAH, Study Reports

News, PAH News

A compound in a plant that is used in traditional Chinese medicine lowered the lung blood pressure of rats with pulmonary arterial hypertension, a study shows The compound, osthole, did ... Read more

April 6, 2018April 6, 2018

Phase 2 Trial of Levosimendan to Treat PH Linked to Specific Heart Failure Moving Forward

News, PH News

Plans for a Phase 2 clinical trial of levosimendan, a proposed treatment for pulmonary hypertension associated with heart failure and preserved ejection fraction, will soon be submitted to the U.S. Food ... Read more

March 22, 2018March 22, 2018

Blood-flow Measurements Could Predict Outcomes of Heart-related Pulmonary Hypertension, Study Finds

News, PH News

American researchers have identified three blood-flow measurements that could help doctors predict the outcomes of people whose pulmonary hypertension stems from a serious heart condition. The discovery applies to ... Read more

February 28, 2018March 1, 2018

Kidney Disease Patients with Pulmonary Hypertension Face Poorer Outcomes, Study Finds

News

Many people with chronic kidney disease also have pulmonary hypertension, a condition that increases their risk of heart problems and death, a review of 16 studies found. Doctors refer to ... Read more

December 22, 2017December 22, 2017

Phase 1 Trial for Camurus’ Long-acting CAM2043 Gets Underway

News, PAH News

The first healthy participants have been injected with CAM2043 (treprostinil FluidCrystal Injection Depot) in a Phase 1 study assessing the treatment’s safety, tolerability, and pharmacokinetics in both single and ... Read more

December 15, 2017December 15, 2017

Balloon Pulmonary Angioplasty May Be ‘Important Therapeutic Option’ in CTEPH Patients, Study Suggests

CTEPH News, News

Patients with blood clots in the lungs known as chronic thromboembolic pulmonary hypertension (CTEPH) can benefit from balloon pulmonary angioplasty (BPA), a new study shows. The procedure is an ... Read more

December 4, 2017December 4, 2017

PhaseBio Secures $15.6M to Fund Clinical Development of Treatment for PAH, Other Orphan Therapies

News, PAH News

PhaseBio Pharmaceuticals has secured $15.6 million in funds to develop its pipeline for orphan drugs led by PB1046, which is designed to treat pulmonary arterial hypertension (PAH), heart failure, cardiomyopathy ... Read more

October 27, 2017October 27, 2017

Researchers Identify Risk Factors for PAH Progression in SSc-PAH patients

News

Male gender and lung function parameters have been identified as risk factors for progression of pulmonary arterial hypertension in patients with systemic sclerosis-PAH (SSc-PAH), a study shows. Part of the larger, ... Read more

Pin It on Pinterest